IPPK expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.247000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.945000E-01
Normal-vs-Stage2
4.089200E-01
Normal-vs-Stage3
1.361820E-01
Normal-vs-Stage4
8.088200E-01
Stage1-vs-Stage2
2.403400E-01
Stage1-vs-Stage3
5.019700E-02
Stage1-vs-Stage4
7.410800E-01
Stage2-vs-Stage3
6.026100E-02
Stage2-vs-Stage4
5.894800E-01
Stage3-vs-Stage4
4.846100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.373400E-01
Normal-vs-AfricanAmerican
5.847600E-01
Normal-vs-Asian
4.745200E-01
Caucasian-vs-AfricanAmerican
8.143000E-01
Caucasian-vs-Asian
5.370800E-01
AfricanAmerican-vs-Asian
8.627000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.883600E-01
Normal-vs-Female
5.925600E-01
Male-vs-Female
6.358200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.294200E-01
Normal-vs-Age(41-60Yrs)
9.452800E-01
Normal-vs-Age(61-80Yrs)
4.034600E-01
Normal-vs-Age(81-100Yrs)
2.324200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.987400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.191400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.539790E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.677300E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.229550E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.864800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.833590E-01
Normal-vs-Daily Drinker
3.674200E-01
Normal-vs-Weekly Drinker
4.523800E-01
Normal-vs-Occasional Drinker
8.513200E-01
Normal-vs-Social Drinker
9.482000E-01
Non Drinker-vs-Daily Drinker
2.555000E-01
Non Drinker-vs-Weekly Drinker
3.380200E-01
Non Drinker-vs-Occasional Drinker
2.264100E-03
Non Drinker-vs-Social Drinker
7.021800E-03
Daily Drinker-vs-Weekly Drinker
9.833800E-01
Daily Drinker-vs-Occasional Drinker
3.453800E-02
Daily Drinker-vs-Social Drinker
7.042400E-02
Weekly Drinker-vs-Occasional Drinker
8.084400E-02
Weekly Drinker-vs-Social Drinker
1.341800E-01
Occasional Drinker-vs-Social Drinker
8.156000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.122600E-01
Normal-vs-Grade 2
6.601800E-01
Normal-vs-Grade 3
6.690000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.858800E-01
Grade 1-vs-Grade 3
8.029400E-01
Grade 1-vs-Grade 4
3.122600E-01
Grade 2-vs-Grade 3
8.432600E-01
Grade 2-vs-Grade 4
6.601800E-01
Grade 3-vs-Grade 4
6.690000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.188400E-01
Normal-vs-NonDiabetic
5.740000E-01
Diabetic-vs-NonDiabetic
1.250050E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.593400E-01
Normal-vs-NoPancreatitis
5.296000E-01
Pancreatitis-vs-NoPancreatitis
5.039000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.745800E-01
Normal-vs-N1
3.860600E-01
N0-vs-N1
7.766400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.980200E-01
Normal-vs-TP53-NonMutant
8.089400E-01
TP53-Mutant-vs-TP53-NonMutant
2.432400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
